Atlas Trials

Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)

Clinical trial NCT03833362 · COMPLETED

Trial details

NCT number
NCT03833362
Sponsor
R-Pharm
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2014-05-07
Primary completion
2016-03-23
Enrollment
420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.